₹1,557.6
▲ +3.26 +0.21%
17 Jul 2026
NSE Listed · Pharmaceuticals
Laurus Labs Limited (LAURUSLABS)
Volume: 10,01,677Avg Vol 1W: 5,07,762Avg Vol 1M: 10,59,38852W Range:₹810.05₹1,579.1
Key Ratios
Checked just nowMarket Cap₹84,149 Cr
Current Price₹1,557.6
Previous Close₹1,554.34
High / Low (52w)₹1,579.1 / ₹810.05
Volume10,01,677
Avg Vol (1W)5,07,762
Avg Vol (1M)10,59,388
Stock P/E301.28
Book Value₹98.11
Dividend Yield13%
ROE16.77%
ROA8.47%
Revenue (TTM)—
Revenue Growth22.67%
Profit Margin13.05%
Total Debt₹611 Cr
Shares Outstanding54 Cr
Face Value₹2
EPS (TTM)₹16.56
P/B15.88
Debt / Equity0.48
50 DMA₹1,474.53
200 DMA₹1,234
Day change+0.21%
Price Chart
₹1,557.6▲ 58.83% · 1Y
2025-11-242026-07-16
20-day avg volume: 10.1L shares
Pros
- Healthy return on equity of 16.8%.
- Pays a dividend yield of 13.0%.
- Company is almost debt-free.
- Revenue grew 22% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 301.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,195 Cr | ₹1,224 Cr | ₹1,415 Cr | ₹1,720 Cr | ₹1,570 Cr | ₹1,653 Cr | ₹1,778 Cr | ₹1,812 Cr |
| EBITDA | ₹68 Cr | ₹75 Cr | ₹188 Cr | ₹369 Cr | ₹276 Cr | ₹310 Cr | ₹365 Cr | ₹402 Cr |
| Net Profit | ₹13 Cr | ₹20 Cr | ₹92 Cr | ₹234 Cr | ₹163 Cr | ₹195 Cr | ₹252 Cr | ₹279 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,308 Cr | ₹2,838 Cr | ₹4,837 Cr | ₹4,951 Cr | ₹6,047 Cr | ₹5,067 Cr | ₹5,629 Cr | ₹6,868 Cr |
| EBITDA | ₹208 Cr | ₹383 Cr | ₹1,369 Cr | ₹1,186 Cr | ₹1,274 Cr | ₹419 Cr | ₹700 Cr | ₹1,353 Cr |
| Net Profit | ₹94 Cr | ₹255 Cr | ₹984 Cr | ₹828 Cr | ₹790 Cr | ₹161 Cr | ₹358 Cr | ₹889 Cr |
| EPS | 8.8 | 4.79 | 18.28 | 15.35 | 14.64 | 2.97 | 6.64 | 16.45 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,331 Cr | ₹3,750 Cr | ₹5,751 Cr | ₹6,968 Cr | ₹7,660 Cr | ₹8,387 Cr | ₹9,336 Cr | ₹10,511 Cr |
| Total Liabilities | ₹1,773 Cr | ₹1,981 Cr | ₹3,150 Cr | ₹3,609 Cr | ₹3,612 Cr | ₹4,271 Cr | ₹4,733 Cr | ₹5,080 Cr |
| Equity | ₹1,558 Cr | ₹1,770 Cr | ₹2,601 Cr | ₹3,359 Cr | ₹4,049 Cr | ₹4,116 Cr | ₹4,603 Cr | ₹5,431 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹323 Cr | ₹387 Cr | ₹962 Cr | ₹1,093 Cr | ₹1,279 Cr | ₹770 Cr | ₹739 Cr | ₹1,917 Cr |
| Investing | ₹-253 Cr | ₹-221 Cr | ₹-941 Cr | ₹-914 Cr | ₹-996 Cr | ₹-822 Cr | ₹-682 Cr | ₹-1,089 Cr |
| Financing | ₹-45 Cr | ₹-128 Cr | ₹255 Cr | ₹30 Cr | ₹-27 Cr | ₹250 Cr | ₹39 Cr | ₹-525 Cr |
| Free Cash Flow | ₹323 Cr | ₹387 Cr | ₹962 Cr | ₹1,093 Cr | ₹1,279 Cr | ₹770 Cr | ₹739 Cr | ₹1,917 Cr |
Shareholding
Promoter 27.49% Institutions 39.79% Public 32.71%
Efficiency & Working Capital
ROCE15%
Interest Coverage7.9
Dividend Payout—
Debtor Days115 d
Inventory Days125 d
Payable Days67 d
Cash Conversion Cycle174 d
Working Capital Days241 d
Shareholding Details
As of 2026-03-31
Promoter27.5%
FII25.8%
DII14%
Institutions39.8%
Public32.7%
Promoter Pledge2.7%
No. of Shareholders2,92,281
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.2% | 27.2% | 27.2% | 27.2% | 27.2% | 27.2% | 27.6% | 27.6% | 27.6% | 27.6% | 27.5% | 27.5% |
| FIIs | 22.5% | 24% | 25.4% | 26% | 25.7% | 26.1% | 25.6% | 25.5% | 25.7% | 26.2% | 26.5% | 25.8% |
| DIIs | 10.1% | 10.7% | 10.8% | 11.8% | 13.6% | 13% | 12.7% | 11.8% | 11.9% | 11.7% | 12.4% | 14% |
| Public | 40.1% | 38.1% | 36.7% | 35.1% | 33.6% | 33.7% | 34.1% | 35.1% | 34.8% | 34.5% | 33.6% | 32.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% |
| No. of Shareholders | 4,17,977 | 4,02,640 | 3,82,880 | 3,56,830 | 3,24,059 | 3,09,063 | 2,92,214 | 2,92,905 | 2,80,223 | 2,83,678 | 2,80,756 | 2,92,281 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| M/s. Nsn Holdings (represented By Its Managing Partner, Dr. Satyanarayana Chava) | Shareholding of Promoter and Promoter Group | 23% | 12.41 Cr |
| New World Fund Inc | Public Shareholding | 4.8% | 2.58 Cr |
| Mirae Asset Large & Midcap Fund | Public Shareholding | 4.5% | 2.41 Cr |
| Smallcap World Fund, Inc | Public Shareholding | 3.4% | 1.83 Cr |
| Anukar Projects Private Limited | Public Shareholding | 3.2% | 1.75 Cr |
| Chunduru Venkata Lakshmana Rao | Shareholding of Promoter and Promoter Group | 2.7% | 1.43 Cr |
| Barclays Wealth Trustees India Private Limited | Public Shareholding | 1.6% | 86,69,184 |
| Akash Bhanshali | Public Shareholding | 1.3% | 71,51,700 |
| M/s. Leven Holdings (represented By Its Managing Partner, Mr. Venkata Ravi Kumar Vantaram) | Shareholding of Promoter and Promoter Group | 1.2% | 62,05,000 |
| Kotak Funds - India Midcap Fund | Public Shareholding | 1.1% | 57,30,000 |
| Satyanarayana Chava | Shareholding of Promoter and Promoter Group | 0.3% | 15,70,000 |
| Venkata Ravi Kumar Vantaram | Shareholding of Promoter and Promoter Group | 0.2% | 10,00,000 |
| Krishnaveni Vasireddi | Shareholding of Promoter and Promoter Group | 0% | 2,01,401 |
| Hymavathi Vantaram | Shareholding of Promoter and Promoter Group | 0% | 2,25,000 |
| Rama Suryadevara | Shareholding of Promoter and Promoter Group | 0% | 1,40,000 |
| Narasimha Rao Suryadevara | Shareholding of Promoter and Promoter Group | 0% | 1,47,500 |
| Nagamani Thokala | Shareholding of Promoter and Promoter Group | 0% | 1,00,000 |
| Kamala Kommana | Shareholding of Promoter and Promoter Group | 0% | 1,00,000 |
| Sekhar Babu Chunduru | Shareholding of Promoter and Promoter Group | 0% | 1,00,000 |
| Chava Narasimha Rao | Shareholding of Promoter and Promoter Group | 0% | 1,19,675 |
| Chandrakanth Chereddi | Shareholding of Promoter and Promoter Group | 0% | 42,000 |
| Chava Naga Rani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Soumya Chava | Shareholding of Promoter and Promoter Group | 0% | 22,940 |
| Krishna Chaitanya Chava | Shareholding of Promoter and Promoter Group | 0% | 20,699 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Satyanarayana Chava | 0 | 0% | 2026-03-31 |
| Chava Naga Rani | 0 | 0% | 2026-03-31 |
| Venkata Ravi Kumar Vantaram | 0 | 0% | 2026-03-31 |
| Chunduru Venkata Lakshmana Rao | 40,00,000 | 28% | 2026-03-31 |
| Chava Narasimha Rao | 0 | 0% | 2026-03-31 |
| Chandrakanth Chereddi | 0 | 0% | 2026-03-31 |
| Krishnaveni Vasireddi | 0 | 0% | 2026-03-31 |
| Sekhar Babu Chunduru | 0 | 0% | 2026-03-31 |
| Hymavathi Vantaram | 0 | 0% | 2026-03-31 |
| Soumya Chava | 0 | 0% | 2026-03-31 |
| Krishna Chaitanya Chava | 0 | 0% | 2026-03-31 |
| Kamala Kommana | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ravindranath Kancherla | Chairman & Independent Directo | 2026 |
| CHAVA SATYANARAYANA | Executive Director & CEO | 2026 |
| VENKATA RAVI KUMAR VANTARAM | Executive Director & CFO | 2026 |
| Venkata Lakshmana Rao Chunduru | Executive Director | 2026 |
| KRISHNA CHAITANYA CHAVA | Executive Director | 2026 |
| Soumya Chava | Executive Director | 2026 |
| Aruna Bhinge | Independent Non Exe. Director | 2026 |
| Rajesh Koshy Chandy | Independent Non Exe. Director | 2026 |
| Karnam Sekar | Independent Non Exe. Director | 2026 |
| Ramesh Subrahmanian | Independent Non Exe. Director | 2026 |
| Sutapa Banerjee | Independent Director | 2026 |
| Shekhar Chintamani Mande | Independent Director | 2026 |
| Venkateswar Reddy Gogireddy | CS / Compliance Officer / Vice President - Legal | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹1,148 Cr | 99% |
| Infosystems | ₹12 Cr | 1% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Outside India | ₹1,016 Cr | 49.1% |
| Within India | ₹1,053 Cr | 50.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹2 | 111 | 108 | 108 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-24 | Board Meetings | — |
| dividend | 2026-05-08 | ₹1.2 (60%) | Interim 2 |
| dividend | 2025-10-31 | ₹0.8 (40%) | Interim 1 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 1,449 | 16 | 49 | 123 | 33 | 1,672 |
| 2026 | 454 | 9 | 49 | 0 | 0 | 512 |
| 2026 | 894 | 7 | 0 | 123 | 30 | 1,056 |
Insider / Designated-Person Trades
20 recent disclosure(s)
PRATHIMA CHAVAPledge · 2,00,000
Mrs. G. SreelakshmiDisposal · 10,000
Venkata Jayasree Kumari TadikondaAcquisition · 788
Venkata Jayasree Kumari TadikondaAcquisition · 3,992
Venkata Jayasree Kumari TadikondaAcquisition · 2,906
MADHURI MEDASANIAcquisition · 10,000
Substantial Acquisitions (SAST)
8 disclosure(s)
Market18/02/2026 · 1,11,064
Market29/07/2025 · 8,58,801
Market30/01/2025 · 2,99,750
Market29/08/2024 · 93,294
Market06/08/2024 · 11,01,072
Market05/06/2024 · 4,24,675
Company Information
Incorporated2005
ChairmanRavindranath Kancherla
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]; [email protected]
📍 Plot No 21 Jawaharlal Nehru, Pharma City Parawada, Visakhapatnam, Andhra Pradesh, 531021
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search